<DOC>
	<DOC>NCT00320918</DOC>
	<brief_summary>Chart Review on Patients with unresectable/metastatic cholangiocarcinoma treated in the UNM Cancer Center with a combination of irinotecan, capecitabine and celecoxib.</brief_summary>
	<brief_title>Chart Review: Unresectable/Metastatic Cholangiocarcinoma Treated With Irinotecan, Capecitabine and Celecoxib</brief_title>
	<detailed_description>As above.</detailed_description>
	<mesh_term>Cholangiocarcinoma</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Irinotecan</mesh_term>
	<mesh_term>Celecoxib</mesh_term>
	<criteria>Patients with unresectable/metastatic cholangiocarcinoma treated in the UNM Cancer Center with a combination of irinotecan, capecitabine and celecoxib. Not specified.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>Unresectable/metastatic cholangiocarcinoma</keyword>
	<keyword>Cancer</keyword>
	<keyword>Chart Review</keyword>
</DOC>